The estimated Net Worth of Colin Shannon is at least $163 Milión dollars as of 17 June 2021. Mr. Shannon owns over 442,241 units of PRA Health Sciences Inc stock worth over $82,087,397 and over the last 9 years he sold PRAH stock worth over $73,698,663. In addition, he makes $7,160,220 as Chairman of the Board, President a Chief Executive Officer at PRA Health Sciences Inc.
Sign up
Mr. Shannon PRAH stock SEC Form 4 insiders trading
Colin has made over 11 trades of the PRA Health Sciences Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he exercised 442,241 units of PRAH stock worth $20,621,698 on 17 June 2021.
The largest trade he's ever made was exercising 442,241 units of PRA Health Sciences Inc stock on 17 June 2021 worth over $20,621,698. On average, Colin trades about 119,721 units every 121 days since 2016. As of 17 June 2021 he still owns at least 496,867 units of PRA Health Sciences Inc stock.
You can see the complete history of Mr. Shannon stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Colin Shannon biography
Colin Shannon was President, Chief Executive Officer, Director of the Company. On January 1, 2010, Mr. Shannon was named PRA's President and Chief Executive Officer and as a director of the Company. He is currently the Chairman of our Board. Mr. Shannon joined PRA in 2007, serving first as President and Chief Operating Officer. Prior to joining PRA, he was Executive Vice President, Global Clinical Operations at Pharmaceutical Product Development, Inc. (now known as Pharmaceutical Product Development LLC) , or PPD. During his 12 year tenure with PPD, he held various leadership roles, including Chief Operating Officer for its European division and Chief Financial and Administration Officer for Europe and the Pacific Rim. Prior to joining PPD, Mr. Shannon had more than 15 years of experience in a variety of financial and accounting positions in the utility and multimedia industries. Mr. Shannon earned his M.B.A. from London's City University and is a fellow member of the Chartered Association of Certified Accountants.
What is the salary of Colin Shannon?
As the Chairman of the Board, President a Chief Executive Officer of PRA Health Sciences Inc, the total compensation of Colin Shannon at PRA Health Sciences Inc is $7,160,220. There are no executives at PRA Health Sciences Inc getting paid more.
How old is Colin Shannon?
Colin Shannon is 60, he's been the Chairman of the Board, President a Chief Executive Officer of PRA Health Sciences Inc since 2014. There are 3 older and 7 younger executives at PRA Health Sciences Inc. The oldest executive at PRA Health Sciences Inc is Jeffrey Barber, 67, who is the Independent Director.
What's Colin Shannon's mailing address?
Colin's mailing address filed with the SEC is C/O PRA HEALTH SCIENCES, INC., 4130 PARKLAKE AVENUE, SUITE 400, RALEIGH, NC, 27612.
Insiders trading at PRA Health Sciences Inc
Over the last 10 years, insiders at PRA Health Sciences Inc have traded over $5,843,308,181 worth of PRA Health Sciences Inc stock. The most active insiders traders include Fund Holdings L.P.Kkr Fund ..., Fund Holdings L.P.Kkr Fund ... a Pra Investors L.P.Kkr Pra I.... On average, PRA Health Sciences Inc executives and independent directors trade stock every 39 days with the average trade being worth of $280,602,577. The most recent stock trade was executed by Christopher L Gaenzle on 17 June 2021, trading 27,497 units of PRAH stock currently worth $2,773,897.
What does PRA Health Sciences Inc do?
PRA is one of the world's leading global contract research organizations by revenue, providing outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries. PRA's global clinical development platform includes more than 70 offices across North America, Europe, Asia, Latin America, South Africa, Australia and the Middle East and more than 18,100 employees worldwide. Since 2000, PRA has participated in approximately 4,200 clinical trials worldwide. In addition, PRA has participated in the pivotal or supportive trials that led to U.S. Food and Drug Administration or international regulatory approval of more than 100 drugs.
What does PRA Health Sciences Inc's logo look like?
Complete history of Mr. Shannon stock trades at PRA Health Sciences Inc
PRA Health Sciences Inc executives and stock owners
PRA Health Sciences Inc executives and other stock owners filed with the SEC include:
-
Colin Shannon,
Chairman of the Board, President, Chief Executive Officer -
Michael Bonello,
Chief Financial Officer, Executive Vice President -
Colin Shannon,
Chairman, CEO & Pres -
Linda Grais,
Independent Director -
Jeffrey Barber,
Independent Director -
Matthew Young,
Independent Director -
Alexander Dickinson,
Independent Director -
James Momtazee,
Lead Independent Director -
Glen Stettin,
Independent Director -
Christopher Gaenzle,
Executive Vice President, Chief Administrative Officer, General Counsel -
Dr. Michael Kirchengast,
Sr. VP of Scientific Affairs -
Patrick R. Spine,
VP of HR -
Tami Klerr-Naivar,
Exec. VP and Chief Sales & Marketing Officer -
Laurie Hurst,
Sr. Director of Communications & PR -
Thomas Byrne,
VP of Legal Affairs -
Kent Thoelke,
Exec. VP & Chief Scientific Officer -
Margaret Keegan,
Exec. VP & COO -
Pra Investors L.P.Kkr Pra I...,
-
Fund Holdings L.P.Kkr Fund ...,
-
Fund Holdings L.P.Kkr Fund ...,
-
David W Dockhorn,
Executive VP & CCO -
Linda Baddour,
Executive VP & CFO -
Pra Investors L.P.Kkr Pra I...,
-
Group Ltd Kkr Group Holding...,
-
Fund Holdings L.P.Kkr Fund ...,